EquityFlow
›
Companies
› Ambagon Therapeutics
Ambagon Therapeutics
Biotech
· San Carlos, US
US-Dutch biotech developing molecular-glue cancer therapeutics.
Funding history
Date
Round
Amount
Jan 2022
Series A
US-Dutch biotech Ambagon Therapeutics raised an 85M dollar Series A led by Nextech Invest, with RA Capital, Inkef Capital and AbbVie Ventures.
$75.1M
Investors
AbbVie Ventures
Droia Ventures
INKEF Capital
Nextech Invest
RA Capital Management
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →